Seres Therapeutics, Inc. (MCRB) Stock buybacks
Seres Therapeutics, Inc. (MCRB) annual stock buyback history — cash paid to repurchase common stock, per SEC filings.
$33,000FY2017
| Fiscal year | Value | YoY |
|---|---|---|
| FY2017 | $33,000 | — |
Source: SEC XBRL filings · For reference only · Not investment advice
More MCRB financial trends
MCRB RevenueMCRB Net incomeMCRB Net marginMCRB Gross profitMCRB Gross marginMCRB Operating incomeMCRB Operating marginMCRB Operating cash flowMCRB Free cash flowMCRB Capital expendituresMCRB Return on equityMCRB Dividends paidMCRB Total assetsMCRB Total liabilitiesMCRB Shareholders’ equityMCRB overview →